⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RLMD News
Relmada Therapeutics, Inc. Common Stock
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2026 Now Available; Delivers 300-Page Deal Directory Covering 1,107 Companies and Contract-Level Financial Terms Since 2019
globenewswire.com
TVTX
NEXT
RLMD
VIVO
Major Depressive Disorder Clinical Trial Pipeline Boom as 75+ Companies are in the Race for Better Treatments | DelveInsight
globenewswire.com
AXSM
VRTX
RLMD
VSTA
PRAX
NBIX
ALTO
LLY
JNJ
MRK
ABBV
BMY
REGN
BIIB
ANVS
ALEC
LEXX
COYA
NVO
IONQ
NVDA
AMD
INTC
GOOG
MSFT
AMZN
TSLA
AAPL
META
IBM
CRM
ADBE
NFLX
CMCSA
VZ
T
KO
PEP
MCD
DIS
BA
CAT
GE
XOM
CVX
JPM
BAC
WFC
GS
MS
V
MA
HD
WMT
COST
PG
PFE
MRNA
GILD
AMGN
NVS
TAK
EXAS
CRSP
EDIT
NTLA
INCY
ALKS
ACAD
AZN
TEVA
BHC
LULU
UBER
LYFT
SPCE
PLTR
SNOW
DDOG
CRWD
ZS
PANW
FTNT
NOW
ADSK
MCHP
NXPI
ON
QCOM
MU
WDC
SE
MELI
BABA
JD
PDD
NTES
BIDU
IQ
VIPS
NIO
XPEV
LI
RIVN
LCID
PLUG
FCEL
BE
SPWR
ENPH
SEDG
RUN
NEO
CLSK
CRBU
RXRX
DTIL
ADPT
CYTK
IMUX
MNKD
SRPT
BNTX
RVMD
ACRS
EXEL
FGEN
GNTX
HRMY
INSM
ITRM
KODK
LPCN
NCLH
OCGN
ORGO
PACB
PBYI
PEGA
PLRX
PRGS
PTON
PYPL
QGEN
QRVO
RDNT
REPL
ROKU
RYAAY
SAVA
SBAC
SCLX
SDRL
SEIC
SIRI
SMCI
SNPS
SOFI
SPOT
SSYS
STX
SWKS
SYK
TCOM
TEAM
TER
TGT
TMO
TMUS
TXN
UAL
ULTA
UPS
VRSK
WDAY
XEL
XYL
ZBRA
Form 8-K
sec.gov
RLMD
Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
globenewswire.com
RLMD
Form 8-K
sec.gov
RLMD
Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
RLMD
Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
RLMD
Form 8-K
sec.gov
RLMD
Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer
globenewswire.com
RLMD
Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
globenewswire.com
RLMD